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Anew family of cell adhesion molecules has recently been identified by isolating
cDNAs that encode cell surface proteins that uniquely contain domains homolo-
gous to those found in animal lectins, epidermal growth factor, and C3/C4 binding
proteins (1-4) . Membersofthis family described thus farinclude the murine lymph
node homing receptor (mLHR) t , expressed by mouse lymphocytes (1), the human
endothelial leukocyte adhesion molecule 1(ELAM-1), expressed by cytokine-stimulated
endothelial cells (2), and human GMP-140, expressed by activated platelets (3) . In
this report, the cloning ofacDNA that encodes a newhuman lymphocyte-associated
cell surface molecule (LAM-1) is described that represents a new member of this
family of adhesion proteins . The chromosome localization of the LAM-1 gene sug-
gests that this family of proteins may be encoded by a clustered locus of "adhesion
protein" genes .
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Materials and Methods
Molecular Cloning.
￿
The isolation ofhuman tonsilcDNA clones by differential hybridiza-
tion has been described (5) . Nucleotide sequences were determined using the method ofMaxam
and Gilbert (6). Gap penalties of -1 were assessed during homology analysis for each nucleo-
tide or amino acid in the sequence where a gap or deletion occurred .
RNA Blot Analysis.
￿
For Northern blot analysis, ti2 ttg of poly(A)' RNA or 15 ttg of total
cellular RNA was denatured, fractionated by electrophoresis through a 1.1% agarose gel,
and transferred to nitrocellulose or nylon membranes as described (5, 7) . The pLAM-1 cDNA
insert was isolated, nick translated, and hybridized with the filters as described (5, 7) .
In Situ Hybridization .
￿
The LAM-1 cDNA clone was labeled by nick translation using jH
nucleotides to a specific activity of 5 x 107 cpm/p.g . In situ hybridization to metaphase chro-
mosomes from lymphocytes of a normal male individual was carried out using the LAM-1
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30476, and GM15253) and a March of Dimes Grant (1-1000). Address correspondence to Thomas F .
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consensus repeat .
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probe at a concentration of 0.02 kg/A1 of hybridization mixture as described (8). The slides
were exposed for 7 d.
Results
Isolation of the LAM-1 cDNA Clone.
￿
B cell-specific cDNAs were isolated from a
human tonsil cDNA libraryusing differentialhybridization withlabeledcDNAsde-
rived from either B cell (RAJI) RNA or T cell (HSB-2) RNA (5). One ofthe 261
RAJI+ HSB2- cDNA clones isolated, B125, contained a 1.9-kb cDNA insert that
hybridized with a 2.4-kb species found in several B cell lines (5). However, B125 did
not hybridize with any ofthe other RAJI+ HSB2- clones or with mRNA from sev-
eral Tcell lines. The B125 cDNA clone was characterized by restriction mapping
and nucleotide sequence determination. A near full-length 2.3-kb cDNA that hy-
bridized with B125 was isolated, sequenced, and termed pLAM-1 (Fig. 1 A). This
clone contained a 1,181-bp open reading frame that could encode a protein of 372
amino acids (Fig. 1 C).
The amino acid sequence ofLAM-1 predicted a structure typical ofamembrane
glycoprotein. Two potential translation initiation sites were found at nucleotide po-
sitions 53 and 92. The second initiation site confirmed best to the consensus se-
quence foroptimalinitiation (A/G)CCAUG (9) and was followed by a hydrophobic
region of27 amino acids that may represent a signal peptide. The algorithm ofvon
Heijne (10) predicted that the most probable NH2 terminus of the mature protein
would be the Trp at amino acid position 52 (Fig. 1 C). The LAM-1 sequence con-
tained a second hydrophobic region between amino acids 346 and 368 that may
be a transmembrane region. The predicted mature LAM-1 protein would have an
extracellular region of -294 amino acids containing seven potential N-linked car-
bohydrate attachment sites. LAM-1 would have acytoplasmic tail of 17 amino acids
containing eight basic and one acidic residues. The two cytoplasmic Ser residues
may serve as substrates for phosphorylation since protein kinase C phosphorylates
Ser residues that are on the COOH-terminal side ofseveral basic residues. These
results suggest that the processed LAM-1 protein would have an Mr of at least
50,000.
LAM-1 Contains Multiple Distinct Domains.
￿
The proposed extracellular region of
LAM-1 contained a high number of Cys residues (7%) with a general structure,
as depicted in Fig. 1 B. The first 157 amino acids of the protein were homologous
with the low affinity receptor for IgE (11), the asialoglycoprotein receptor (12), and
several othercarbohydrate-binding proteins (13-16)(Fig. 2A). Although the sequence
homologies were <30%, allthe invariant residues found inanimal lectin carbohydrate-
recognition domains were conserved (17). The next domain of36 amino acids was
homologous (36-39%) with epidermal growth factor (EGF) (18) and the EGFlike
repeat units found in factor IX (19) and fibroblast proteoglycan core protein (15)
(Fig. 2 B). Immediately after these domainswere two tandem domains of62 amino
acids each that were homologous with the short consensus repeat units (SCR) that
comprise the IL-2-R (20), factor XIII (21), and many C3/C4 binding proteins (22,
23) (Fig. 2 C). In contrast to all ofthe previously described SCR that contain four
conserved Cys residues, these two SCR possessed six Cysresidues. A15-amino acid
spacer preceded the putative transmembrane domain.
Homology ofLAM-1 with mLHR, SLAM-1, and GMP-140.
￿
LAM-1 shares a 77%FIGURE 1 .
￿
Structure of the pLAM-1 cDNA clone . (A) The restriction map was constructed by
the standard single, double, or triple digestions ofpLAM-1 . The putative coding region is shown
in black. Arrows indicate the direction and extent of nucleotide sequence determination and the
open circles indicate Tend labeling. (B)A schematicmodel ofthe structure oftheLAM-1 mRNA
is shown . Thin lines indicate 5' and 3' untranslated sequences(UT), while the thick bar indicates
thetranslated region . The boxes represent the lectin-like and EGFlike domains and the twoSCR
units . The open box indicates the putative transmembrane (TM) region . (C) The determined
nucleotide sequence and predictedamino acid sequence oftheLAM-1 cDNA clone. Thenumbers
shown above the amino acid sequence designate amino acid residue positions . The numbers to
the right indicate nucleotide residue positions. Amino acids are designated by the single-letter
code, and an asterisk indicates the termination codon . The boxed sequences identify possible
N-linked glycosylation sites. Hydrophobic regions that may identify signal and transmembrane
peptides are underlined . The vertical arrow marks the most probable position of the NH2 ter-
minusofthe mature protein . These sequence data have been submitted to the EMBL/GenBank
Data LihririPS .126
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Homologies ofLAM-1 domainswith otherproteins. Segments of homologous pro-
teins are shown with the amino acid residue numbers at each end. Homologous amino acids
are shownin boxes. Gaps (-) have been inserted in the sequences to maximize homologies. (A)
Lectin-like domain of LAM-1 compared with: FcE-R, theFc receptor forIgE(11);C-HL,chicken
hepaticlectin (13); H-MBP, humanmannose-binding protein (14); F-PGC, fibroblast proteoglycan
core protein (15); HHL-1, humanhepatic lectin-1 (12);ISL, insect solublelectin (16). Theamino
acids conservedamong allanimal lectin carbohydrate recognition domainsareindicated ('). (B)
EGF-like domain of LAM-1 compared with: human EGF (18); FIX, blood clotting factor IX
(19); F-PGCP, fibroblast proteoglycan core protein (15). (C) Short consensus repeats 1 and 2 of
LAM-1 compared with: Ba, proteolytic fragment of factor B (23); CRl, (22); IL-2-R, (20); and
F-XIII, bloodclotting factor XIII (21). The four conserved Cys residues found in all SCR are
indicatedby ('), theadditional conservedCys foundin LAM-1 areindicatedby (+). Ofthemul-
tiple SCRpresent in each of these proteins, the SCR with the highest homology to LAM-1 is
diagrammed.
amino acid sequence homology with the mouse LHR (Fig. 3). Significant homolo-
gies ofnucleotide sequences outside ofthe putative coding regions were not found.
The leader sequence ofmLHR shares a 63% amino acid sequence homology with
LAM-1, while the lectin domains share an 83% homology. The lectin domain of
LAM-1 shares a67 and 61% sequence homology with GMP-140 and ELAM-1, respec-
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￿
Homology of LAM-1
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￿
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homing receptor (1) . Identical
KQ---N-------R------N---K-PY----------KM--------T--K------A----
￿
amino acids are represented (-) .
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￿
the amino acid residue positions
shown in Fig . 1 C . The arrow
VGYYGPQCQFVIQCEPLEAPELGTMDCTHPLGNFNFNSQCAFSCSEGTNLTGIEETTCEPFGN 259
￿
indicates the predicted NH2
A--------Y-V---------------I------S-Q-K---N----RE-L-TA--Q-GAS--
terminus ofLAM-1 and the de-
WSSPEPTCQVIQCEPLSAPDLGIMNCSHPLASFSFTSACTFICSEGTELIGKKKTICESSGIW 322
￿
termined NH2 terminus of
------I---V-----E--E--T-D-I---GN---Q-K-A-N----R--L-TAE-Q-GA--N-
￿
mLHR . The underlined region
SNPSPICQKLDKSFSMIKEGDYNPLFIPVAVMVTAFSGLAFIIWLARRLKKGKKSKRSMNDPY 385
￿
indicates the putative transmem-
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￿
brane region .
tively . TheEGFdomain ofLAM-1 shares an 80, 66, and63% homology with mLHR,
ELAM-1, and GMP-140 domains, respectively. SCR-1 and SCR-2 of LAM-1 are
74 and 61% homologous with the two identicalSCR domains ofmLHR . Most in-
teresting is that the putative transmembrane domains of LAM-1 and mLHR are
95% homologous, while the cytoplasmic tailsare78% homologous . The transmem-
brane and cytoplasmic domains ofLAM-1 share little sequence homology with the
corresponding domains in ELAM-1 and GMP-140.
Expression ofLAM-1 mRNA .
￿
Northern analysis revealed that LAM-1 hybridized
strongly to a 2.6-kb RNA species and weakly to a 1 .7-kb RNA species in poly(A)'
RNA isolated from theB cell lines Raji, SB (Fig . 4 A), Laz-509, and GK-5 (data
not shown) . The 1 .7-kbRNA species may result from alternate use of the potential
poly(A) signal sequence, ATATAAA, at position 1493 (Fig . 1 C), which serves as
FIGURE 4.
￿
RNA blot analysis
with labeled LAM-1 cDNA
probe . (A) Northern blot anal-
ysis of poly(A)' RNA isolated
from B cell lines (Raji, SB,
Daudi, Namalva, Nalm-6), T
cell lines (Hut-78, HSB-2,
Molt-3), and an erythroleuke-
mic cell line (K562) . Ribosomal
RNA was run in parallel as an
indicator of size . (B) Northern
blot analysis ofRNA (15 gg) iso-
lated from blood T cells isolated
by sheep erythrocyte rosetting
before and after culturing with
PHA for 18 h, and monocytes
(MO) isolated by adherence to
plastic and cultured with and
without LPS for 2 h .128
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a poly(A) attachment signal in the mouse LHR cDNA (1). RNA isolated from two
pre-B cell lines (Nalm-6, PB-697), three B cell lines (Namalwa, Daudi, BJAB), five
T cell lines (CEM, Hut-78, HSB-2, Molt-15, Molt-3), a myelomonocytic cell line
(U937 and U937 cultured with LPS), and an erythroleukemic cell line (K-562) did
not hybridizewith LAM-1, suggesting thatexpression ofthisgene was preferentially
associated with B lymphoblastoid cell lines (data not shown). However, analysis of
mRNA isolated from blood lymphocytes and purified blood T cells revealed that
LAM-1 mRNA was readily detected in T cellsand increased after mitogen stimula-
tion(Fig. 4B). Both the 2.6- and 1.7-kb RNA species that hybridized with pLAM-1
were expressed byT cells. Low levels ofLAM-1 mRNAwere detected insomemono-
cyte preparations, but not in others, suggesting that LAM-1 may also be expressed
bymonocytes at amounts farbelow those observed in T lymphocytes. Alternatively,
low numbers oflymphocytes (<2%) contaminating the monocyte preparations may
account for this variability. Treatment of monocytes with Bryostatin 1 or LPS did
not induce LAM-1 mRNA, and LAM-1 mRNAwas not detected in malignant cells
from two patients with chronic myelogenous leukemia (data not shown). In addi-
tion, a human fibroblast cell line (Wi-38 and Wi-38 stimulated with LPS) and pri-
mary cultures of human fibroblasts transfected with the EJ-ras oncogene did not
express detectable LAM-1 mRNA. Human epithelial keratinocytes, untreated or
cultured with LPS or TNF, also failed to express detectable LAM-1 mRNA.
Chromosome Location ofthe LAM-1 Gene.
￿
The LAM-1 gene was localized on human
metaphase chromosomes by in situ hybridization using the LAM-1 cDNA clone as
alabeled probe. Atotal of181 sites ofhybridization in48 metaphase cells were scored
(Fig. 5 a). Ofthe 181 sites ofhybridization, 48 (27%) were located between bands
q22 and q25 ofthe long arm ofchromosome 1. Therewas no significant hybridiza-
tion toother chromosomes (Fig. 5 a). The largest number ofgrains on chromosome
1 were located at bands q23 and q24, with significant hybridization to band q25
(Fig. 5 b).
Discussion
The generation of genes by the assembly of functionally independent domains
has occurred frequently as new genes evolved to encode proteins with new func-
tions. However, LAM-1 combines previously unrelated domains found inthree dis-
tinct families ofmolecules: animal lectins, growth factors, and C3/C4 binding pro-
teins. The LAM-1 lectin-like domainhas homology with mammalian lectins specific
for glycans with terminal galactosyl, N-acetylglucosaminyl, and mannosyl residues
(17), and homology with the lectin-like domain ofthe low affinity Fc receptor for
IgE (11). Most animal carbohydrate-binding receptors, however, differ from LAM-1
since their COOH terminus contains the lectin domain and is on the outside of
the membrane, while their NH2 terminus is inside the cell (17). An exception, like
LAM-1, is the galactose-binding protein from fly hemolymph that has the lectin
domain at the NH2-terminal end ofthe protein (16). Although the carbohydrate-
bindingdomain in flyhemolymphlectin diverged aconsiderable timeago from human
LAM-1, it is homologous (23%) with the LAM-1 lectin-like domain (Fig. 2 A). In-
terestingly, it has been proposed that the lectin isolated from fly hemolymph may
be involved in aprimitive immune response (24). The homology ofanother LAM-1
domainwith proteins that contain EGFlikesequences, such as blood clotting factors,130
￿
NEW HUMAN LYMPHOCYTE-ASSOCIATED ADHESION MOLECULE
suggests that this domain could also interact with other proteins (19). EGFlike re-
peat units are also found injuxtaposition with the lectin domain of fibroblast proteo-
glycan core protein, suggesting that this protein and LAM-1 may be evolutionarily
related (15). The SCR domains may also have receptor function, since the extracellu-
lar domains ofreceptors for many complement components and IL-2 are composed
of SCR domains (20-23).
LAM-1 is a new member of a family of recently described cellular adhesion pro-
teins (1-3) . This family includes the mouse LHR that has a 77% amino acid se-
quence homology with LAM-1 (Fig. 3). Northern analysis of LAM-1 expression
demonstrated a predominantly lymphoid distribution in humans (Fig. 4) that is also
similar to the cell surface expression of the mLHR (1). Since pretreatment of mouse
lymphocytes with specific polysaccharides inhibits their adherence to high endothelial
venules in lymph nodes, the lectin-like domain of LAM-1 may also function in the
adherence oflymphocytes to endothelial cells (25). The lectin-like and EGFlike do-
mains of LAM-1 and mLHR shared considerable homology (83-80%), but the area
of highest homology (95%) was found in the putative transmembrane region, sug-
gesting that these domains may be most critical to the function ofLAM-1 and mLHR.
Although LAM-1 and mLHR are structurally homologous, it is not known whether
LAM-1 functions as the LHR in man . However, preliminary studies demonstrate
that the cell lines that express high levels of LAM-1 mRNA (Fig. 4) bind to human
high endothelial venules, while most of those that do not express LAM-1 mRNA
do not bind (A. Freedman and T F. Tedder, unpublished observations). Therefore,
it is possible that LAM-1 serves a function in man similar to that of the LHR in
mouse.
Other members of this new adhesion molecule family that are homologous with
LAM-1 include the inducible ELAM-1, which is expressed on the surface of cytokine-
treated endothelial cells (2). This molecule is thought to be responsible for the ac-
cumulation of blood leukocytes at sites of inflammation by mediating the adhesion
of cells to the vascular lining. LAM-1 and ELAM-1 exhibit homologous structural
features, including the presence of lectin- and EGFlike domains followed by SCR
domains that contain six conserved Cys residues. In addition, a granule membrane
protein found in platelets and endothelial cells, termed GMP-140, is also homolo-
gous with LAM-1 in that it contains lectin, EGF, and SCR domains (3). These pro-
teins and LAM-1 thus appear to define a new family of homologous structures that
are each expressed by different human cell lineages.
The LAM-1 gene is located on human chromosome 1 at band q23-25 (Fig. 5).
The gene for GMP-140 has also been mapped to chromosome 1 q21-24 (3, McEver,
R., G. Johnston, and M . Le Beau, personal communication). These findings sug-
gest that a cluster of "adhesion molecule" loci may exist on the long arm of chromo-
some 1 in the region q21-25, which contains at least two of the three members of
this human gene family. This locus is distinct from the "complement receptor" locus
at band 1832, which encodes the SCR containing proteins, CR1, CR2, C4-binding
protein, and factor H (26). The finding that two of these new genes map to the same
band of human chromosome 1, in addition to their common structural motif, fur-
ther demonstrates that these proteins are members of a closely related family of
proteins.TEDDER ET AL.
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Summary
A cDNA encoding a new human lymphocyte cell surface molecule has been iso-
lated and shown to identify a fourth member of a recently discovered family of adhe-
sion proteins. This lymphocyte-associated molecule (LAM-1) is uniquely composed
ofmultiple distinct domains, one domain homologous with animal lectins, one ho-
mologous with epidermal growth factor, and two short consensus repeat units similar
to those found in C3/C4 binding proteins. This cDNA clone hybridized with RNAs
found in B cell lines and T lymphocytes, but not with RNA from other cell types.
The amino acid sequence of LAM-1 is 77% homologous with the sequence of the
mouse lymphocyte homing receptor, suggesting that LAM-1 may function in human
lymphocyte adhesion. The LAM-1 gene is located on chromosome lg23-25, as is
another member ofthis adhesion family, suggesting that this new family of proteins
may be encoded by a cluster of "adhesion protein" loci.
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